Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.